Major depressive disorder and co-morbid chronic pain, a costly condition

被引：0
|
作者：
Hunkeler, EM
Arnow, BA
Fireman, B
Lee, J
Robinson, R
Blasley, C
Constantino, MJ
Kraemer, BC
Haywood, C
Dea, R
Swindle, RW
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Stanford Alcohol & Drug Treatment Ctr, Stanford, CA USA
[4] Stanford Med Ctr, Stanford, CA USA
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [1] Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder
    Meighen, Karen G.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (01) : 121 - 127
  • [2] Efficacy of venlafaxine and fluoxetine inpatients with major depressive disorder and co-morbid generalized anxiety disorder
    Silverstone, PH
    Salinas, EO
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S81 - S81
  • [3] Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates
    Bailey, Freddie
    Mondragon-Shem, Karina
    Haines, Lee Rafuse
    Olabi, Amina
    Alorfi, Ahmed
    Ruiz-Postigo, Jose Antonio
    Alvar, Jorge
    Hotez, Peter
    Adams, Emily R.
    Velez, Ivan D.
    Al-Salem, Waleed
    Eaton, Julian
    Acosta-Serrano, Alvaro
    Molyneux, David H.
    PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (02):
  • [4] Initial investigation of behavioral activation therapy for co-morbid major depressive disorder and obesity
    Pagoto, Sherry
    Bodenlos, Jamie S.
    Schneider, Kristin L.
    Olendzki, Barbara
    Spates, C. Richard
    PSYCHOTHERAPY, 2008, 45 (03) : 410 - 415
  • [5] Co-Morbid Recurrent Headaches and Major Depressive Disorder: An RCT of Cognitive Behavior Therapy
    Martin, P. R.
    CEPHALALGIA, 2013, 33 (S8) : 95 - 95
  • [6] Genome wide association scan of co-morbid anxiety in major depressive disorder (MDD)
    Schosser, A.
    Ng, M. Y.
    Butler, A. W.
    Uher, R.
    Cohen-Woods, S.
    Craddock, N.
    Owen, M.
    Aitchison, K. J.
    Breen, G.
    Craig, I.
    Farmer, A. E.
    Lewis, C. M.
    McGuffin, P.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 37 - 37
  • [7] Phase-based psychotherapy as a treatment for dissociative identity disorder co-morbid with major depressive disorder
    Ergul, Humeyra
    Yanik, Medaim
    Uysal, Burcu
    INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2023, 58 : 1024 - 1024
  • [8] Type of Presentation of Dissociative Disorder and Frequency of Co-morbid Depressive Disorder
    Alvi, Tabassum
    Minhas, Fareed Aslam
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2009, 19 (02): : 113 - 116
  • [9] Milnacipran and atomoxetine: treatment of depressive disorder with co-morbid hyperactivity disorder
    Martsenkovsky, I.
    Martsenkovska, I. I.
    Bikshaeva, Y. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S373 - S374
  • [10] SYMPTOM SEVERITY OF MAJOR DEPRESSIVE DISORDER: ASSOCIATIONS WITH FUNCTIONAL DISABILITY, AND PREVALENCE OF CO-MORBID ILLNESSES
    Ong, Wei Jie
    Abdin, Edimansyah
    Chua, Boon Yiang
    Sambasivam, Rajeswari
    Shafie, Saleha
    Vaingankar, Janhavi
    Chong, Siow Ann
    Subramaniam, Mythily
    ASEAN JOURNAL OF PSYCHIATRY, 2018, 19 (02):
12345